Sarepta Therapeutics (SRPT) News Today → Breaking - The US Gov. Seized CITGO (From Augury Research) (Ad) Free SRPT Stock Alerts $123.32 +5.88 (+5.01%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 1:19 PM | marketbeat.comSarepta Therapeutics (NASDAQ:SRPT) Trading Up 4.1%Sarepta Therapeutics (NASDAQ:SRPT) Trading 4.1% HigherJune 7 at 5:01 AM | marketbeat.comSarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Bought by Hsbc Holdings PLCHsbc Holdings PLC lifted its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 1,033.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 28,513 shares of the biotechnology companJune 6 at 7:00 AM | investorplace.comExit Strategy: 3 Overvalued Stocks to Sell Before They DeflateJune 5 at 3:32 PM | marketbeat.comCapital International Investors Purchases 2,917,797 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)Capital International Investors lifted its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 160.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,741,485 shares ofJune 2, 2024 | marketbeat.comAlpha DNA Investment Management LLC Purchases Shares of 5,832 Sarepta Therapeutics, Inc. (NASDAQ:SRPT)Alpha DNA Investment Management LLC purchased a new stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,832 shares of the biotechnology company's stock,May 31, 2024 | businesswire.comSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 31, 2024 | americanbankingnews.comSarepta Therapeutics (NASDAQ:SRPT) Earns Overweight Rating from Analysts at Piper SandlerMay 31, 2024 | marketbeat.comPrincipal Financial Group Inc. Acquires 27,549 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)Principal Financial Group Inc. raised its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 125.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 49,539 shares of the biotechMay 30, 2024 | marketbeat.comSarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up to $116.25Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up to $116.25May 29, 2024 | ca.finance.yahoo.comI:RUT Oct 2024 Weekly 2200.000May 29, 2024 | ca.finance.yahoo.comI:RUT Jun 2024 Weekly 1685.000May 29, 2024 | msn.comWith FDA Decision Date Approaching, Analyst Downgrades Sarepta On Balanced Risk And RewardMay 29, 2024 | finance.yahoo.comIs Sarepta Therapeutics, Inc. (NASDAQ:SRPT) A Good Fast Growth Stock To Buy?May 29, 2024 | marketbeat.comUBS Group AG Acquires 57,805 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)UBS Group AG raised its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 26.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 276,276 shares of the biotechnology company's stock after puMay 29, 2024 | americanbankingnews.comSarepta Therapeutics (NASDAQ:SRPT) Receives Sector Perform Rating from Royal Bank of CanadaMay 28, 2024 | msn.comRBC Capital cuts Sarepta to sector perform ahead of FDA decisionMay 28, 2024 | msn.comRBC Capital Downgrades Sarepta Therapeutics (SRPT)May 28, 2024 | msn.comSarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six MonthsMay 28, 2024 | marketbeat.comSarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down to $123.46Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down to $123.46May 28, 2024 | marketbeat.comSarepta Therapeutics (NASDAQ:SRPT) Given Sector Perform Rating at Royal Bank of CanadaRoyal Bank of Canada reaffirmed a "sector perform" rating and issued a $142.00 price target (down previously from $157.00) on shares of Sarepta Therapeutics in a report on Tuesday.May 28, 2024 | ca.finance.yahoo.comSRPT Jun 2024 143.000 callMay 26, 2024 | marketbeat.com836,849 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Bought by Norges BankNorges Bank purchased a new stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 836,849 shares of the biotechnology company's stock, valued at approximately $80,697,000. Norges Bank owned aboMay 25, 2024 | marketbeat.comClearbridge Investments LLC Buys New Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)Clearbridge Investments LLC purchased a new position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 151,127 shares of the biotechnology company's stock, valued at approximately $14,573,0May 24, 2024 | benzinga.comDecoding Sarepta Therapeutics's Options Activity: What's the Big Picture?May 24, 2024 | finance.yahoo.comImplied Volatility Surging for Sarepta (SRPT) Stock OptionsMay 23, 2024 | investorplace.comThe 2030 Millionaire's Club: 3 Biotech Stocks to Buy NowMay 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Sarepta Therapeutics (SRPT)May 22, 2024 | marketbeat.com67,433 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Bought by Trexquant Investment LPTrexquant Investment LP acquired a new position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 67,433 shares of the biotechnolMay 22, 2024 | benzinga.comJim Cramer: This Industrial Stock Is Doing 'Very Well'; Here's His Take On PalantirMay 21, 2024 | marketbeat.comTraders Buy High Volume of Sarepta Therapeutics Call Options (NASDAQ:SRPT)Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Stock traders purchased 3,559 call options on the company. This represents an increase of 71% compared to the average daily volume of 2,081 call options.May 20, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Sol-Gel Technologies (SLGL)May 20, 2024 | markets.businessinsider.com12 Analysts Have This To Say About Sarepta TherapeuticsMay 20, 2024 | marketbeat.comSarepta Therapeutics (NASDAQ:SRPT) Rating Reiterated by Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $166.00 price objective on shares of Sarepta Therapeutics in a report on Monday.May 19, 2024 | marketbeat.comSarepta Therapeutics, Inc. (NASDAQ:SRPT) Stake Lifted by Mizuho Markets Americas LLCMizuho Markets Americas LLC increased its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 24.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30May 17, 2024 | markets.businessinsider.comBuy Rating for Sarepta Therapeutics’ Elevidys Supported by Positive Regulatory SignalsMay 17, 2024 | marketbeat.comThornburg Investment Management Inc. Grows Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)Thornburg Investment Management Inc. increased its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 138.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 40,345 shares of the biotechnoloMay 17, 2024 | marketbeat.comSarepta Therapeutics (NASDAQ:SRPT) PT Raised to $179.00 at MizuhoMizuho lifted their price target on shares of Sarepta Therapeutics from $145.00 to $179.00 and gave the company a "buy" rating in a research note on Friday.May 17, 2024 | marketbeat.comSarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by Fiera Capital CorpFiera Capital Corp cut its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 2.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 348,212 shares of the biotechnology company's stock after selling 8,111 shares duriMay 15, 2024 | marketbeat.com203,882 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Bought by First Turn Management LLCFirst Turn Management LLC bought a new stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 203,882 shares of the biotechnology company's stock, vMay 14, 2024 | marketbeat.comNicholas Investment Partners LP Sells 2,084,756 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)Nicholas Investment Partners LP lessened its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 99.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,329 shares of the biotechnology companyMay 14, 2024 | msn.comRoblox downgraded, Western Digital initiated: Wall Street's top analyst callsMay 14, 2024 | msn.comOppenheimer Upgrades Sarepta Therapeutics (SRPT)May 14, 2024 | msn.comSarepta upgraded at Oppenheimer on potential Elevidys label expansionMay 14, 2024 | marketbeat.comOppenheimer Upgrades Sarepta Therapeutics (NASDAQ:SRPT) to "Outperform"Oppenheimer raised shares of Sarepta Therapeutics from a "market perform" rating to an "outperform" rating and set a $180.00 target price on the stock in a research note on Tuesday.May 11, 2024 | marketbeat.comSwiss National Bank Sells 17,800 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)Swiss National Bank lowered its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 156,283 shares of the biotechnology company's stock afMay 7, 2024 | insidertrades.comSarepta Therapeutics, Inc. (NASDAQ:SRPT) Insider Dallan Murray Sells 3,635 SharesMay 6, 2024 | marketbeat.comInsider Selling: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Insider Sells 3,635 Shares of StockSarepta Therapeutics, Inc. (NASDAQ:SRPT - Get Free Report) insider Dallan Murray sold 3,635 shares of the business's stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $140.00, for a total value of $508,900.00. Following the completion of the sale, the insider now owns 18,125 shares in the company, valued at $2,537,500. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.May 5, 2024 | marketbeat.com10,146 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Acquired by Sapient Capital LLCSapient Capital LLC purchased a new stake in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 10,146 shares of the biotechnology company's stock,May 5, 2024 | finance.yahoo.comEarnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsMay 4, 2024 | investorplace.com3 Biotech Stocks With the Potential to Make You an Overnight Millionaire Get Sarepta Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 AI Stocks to Buy for 2024 (Ad)The electric vehicle boom is accelerating – and fast. Click to View The 5 Best AI Stocks to Invest In SRPT Media Mentions By Week SRPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRPT News Sentiment▼0.990.73▲Average Medical News Sentiment SRPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRPT Articles This Week▼59▲SRPT Articles Average Week Get Sarepta Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Mirati Therapeutics News Today PTC Therapeutics News Today ACADIA Pharmaceuticals News Today Wave Life Sciences News Today Solid Biosciences News Today Takeda Pharmaceutical News Today Teva Pharmaceutical Industries News Today Alnylam Pharmaceuticals News Today Genmab A/S News Today Royalty Pharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRPT) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredWarren Buffett & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored